Developmental and Functional Control of Natural Killer Cells by Cytokines

Natural killer (NK) cells are effective in combating infections and tumors and as such are tempting for adoptive transfer therapy. However, they are not homogeneous but can be divided into three main subsets, including cytotoxic, tolerant, and regulatory NK cells, with disparate phenotypes and funct...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 8; p. 930
Main Authors Wu, Yang, Tian, Zhigang, Wei, Haiming
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 04.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Natural killer (NK) cells are effective in combating infections and tumors and as such are tempting for adoptive transfer therapy. However, they are not homogeneous but can be divided into three main subsets, including cytotoxic, tolerant, and regulatory NK cells, with disparate phenotypes and functions in diverse tissues. The development and functions of such NK cells are controlled by various cytokines, such as fms-like tyrosine kinase 3 ligand (FL), kit ligand (KL), interleukin (IL)-3, IL-10, IL-12, IL-18, transforming growth factor-β, and common-γ chain family cytokines, which operate at different stages by regulating distinct signaling pathways. Nevertheless, the specific roles of each cytokine that regulates NK cell development or that shapes different NK cell functions remain unclear. In this review, we attempt to describe the characteristics of each cytokine and the existing protocols to expand NK cells using different combinations of cytokines and feeder cells. A comprehensive understanding of the role of cytokines in NK cell development and function will aid the generation of better efficacy for adoptive NK cell treatment.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Kamalakannan Rajasekaran, Genentech, Inc., United States; Martin R. Goodier, London School of Hygiene & Tropical Medicine, United Kingdom
Specialty section: This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology
Edited by: Eleanor Riley, London School of Hygiene & Tropical Medicine, United Kingdom
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2017.00930